Windtree signs a new financing protocol of 520 million USD to strengthen its BNB reserve strategy.

robot
Abstract generation in progress

ChainCatcher news, Nasdaq-listed biotechnology company Windtree Therapeutics (WINT) announced that it has signed a common stock purchase agreement of up to $500 million to establish an equity line of credit (ELOC). In addition, the company has also signed an additional stock purchase agreement worth $20 million with Build and Build Corp. The total financing scale reaches up to 520 million dollars, of which 99% of the funds will be used to purchase BNB. The company plans to officially start using the funds after obtaining shareholder approval to increase the authorized number of common stocks.

BNB2.93%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)